Oxford BioDynamics PLC

Company Profile

• Business description

  Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.

• Contact

  John Smith Drive
  3140 Rowan Place
  Oxford Business Park South
  OxfordOX4 2WB
  GBR

  T: +44 1865518910

  E: [email protected]

  https://www.oxfordbiodynamics.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Diagnostics & Research

  Fiscal Year End

  30 September 2026

  Employees

  51